Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aralez Pharmaceuticals Inc.

http://aralez.com/

Latest From Aralez Pharmaceuticals Inc.

Cheplapharm Benefits As Takeda Sheds More Older Products

Japanese major presses on with post-Shire divestments even after passing strategic target.

Business Strategies Deals

Takeda Confirms $2.3bn Deal With Blackstone For Japan Consumer Business

In a widely anticipated move, Takeda has confirmed the sale of its consumer healthcare business in Japan, to the US private equity group Blackstone.

Japan Commercial

Blackstone Emerges As Likely Buyer For Takeda's OTC Business At Price Close To $3Bn

Takeda's divestment long has been rumored and would take it to its oft-stated target of selling around $10bn in assets to pay down debt associated with its $62bn purchase of Shire that closed in January 2019.

Manufacturing OTC Drugs

Blackstone Emerges As Likely Buyer Of Takeda OTC Business

Private equity group Blackstone is reportedly near a deal to acquire Takeda's consumer health business in Japan for up to $2.8bn as the Japanese pharma firm continues to shed non-core assets.

Japan Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Medical Futures Inc.
    • POZEN Inc.
    • Stellar Pharmaceuticals, Inc. (SLXCF)
    • Tribute Pharmaceuticals Inc.
UsernamePublicRestriction

Register